Development of carvedilol-loaded lipid nanoparticles with compatible lipids and enhanced skin permeation in different skin models

References

• Abd, E., et al., 2016. Skin models for the testing of transdermal drugs. Clinical pharmacology, 8, 163–176.
   PubMedGoogle Scholar
• Agrawal, S.S., and Aggarwal, A., 2010. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study. Contemporary clinical trials, 31 (4), 272–278.
   PubMed Web of Science ®Google Scholar
• Amasya, G., et al., 2016. Skin localization of lipid nanoparticles (SLN/NLC): focusing the influence of formulation parameters. Current drug delivery, 13, 1100–1110.
   PubMed Web of Science ®Google Scholar
• Andrade, L.M., et al., 2014. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. European journal of pharmaceutics and biopharmaceutics, 88, 40–47.
   PubMed Web of Science ®Google Scholar
• Andrade, L.M., et al., 2017. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: study of drug effects in lipid matrix by electron paramagnetic resonance. European journal of pharmaceutics and biopharmaceutics, 119, 142–149.
   PubMed Web of Science ®Google Scholar
• Boakye, C.H., Patel, K., and Singh, M., 2015. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers. International journal of pharmaceutics, 489 (1–2), 106–116.
   PubMed Web of Science ®Google Scholar
• Chakraborty, S., et al., 2011. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate. Journal of pharmacy and pharmacology, 63, 774–779.
   PubMed Web of Science ®Google Scholar
• Dash, S., et al., 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta poloniae pharmaceutica, 67, 217–223.
   PubMed Web of Science ®Google Scholar
• Dixit, N., Kohli, K., and Baboota, S., 2008. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug. PDA journal of pharmaceutical science and technology, 62, 46–55.
   PubMedGoogle Scholar
• Djekic, L., and Primorac, M., 2008. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. International journal of pharmaceutics, 352, 231–239.
   PubMed Web of Science ®Google Scholar
• Dulin, B., and Abraham, W.T., 2004. Pharmacology of carvedilol. The American journal of cardiology, 93 (9), 3–6.
   Web of Science ®Google Scholar
• Food and Drug Administration. 1996. Guidance for industry: Q2B validation of analytical procedures: methodology. Rockville, MD, United States: FDA.
   Google Scholar
• Food and Drug Administration. 1997. Guidance for industry: dissolution testing of immediate release solid oral dosage forms. Rockville, MD, United States: FDA.
   Google Scholar
• Organisation for Economic Co-operation and Development. 2004. Guideline 428: skin absorption: in vitro methods. Paris: OECD. Q2B Validation of Analytical Procedures: Methodology Guidance for Industry: Bioanalytical Method Validation. United States: FDA.
   Google Scholar
• Ganguly, R., et al., 2019. Salt and phytochemical assisted modulation of self-assembly characteristics of Polysorbate-80 in aqueous medium. International journal of pharmaceutics, 563, 63–70.
   PubMed Web of Science ®Google Scholar
• Godin, B., and Touitou, E., 2007. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Advanced drug delivery reviews, 59, 1152–1161.
   PubMed Web of Science ®Google Scholar
• Gulbake, A., et al., 2010. Solid lipid nanoparticles bearing oxybenzone: in-vitro and in-vivo evaluation. Journal of microencapsulation, 27 (3), 226–233.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2013. Topical delivery of enoxaparin using nanostructured lipid carrier. Journal of microencapsulation, 30 (7), 709–715.
   PubMed Web of Science ®Google Scholar
• Kligman, A.M., and Christophers, E., 1963. Preparation of isolated sheets of human stratum corneum. Archives of dermatology, 88, 702–705.
   PubMed Web of Science ®Google Scholar
• Kshirsagar, S.J., Bhalekar, M.R., and Mohapatra, S.K., 2012. Development and evaluation of carvedilol-loaded transdermal drug delivery system: in-vitro and in-vivo characterization study. Drug development and industrial pharmacy, 38 (12), 1530–1537.
   PubMed Web of Science ®Google Scholar
• Leal, L.B., et al., 2013. Determination of the critical hydrophile-lipophile balance of licuri oil from Syagrus coronata: application for topical emulsions and evaluation of its hydrating function. Brazilian journal of pharmaceutical sciences, 49 (1), 167–173.
   Web of Science ®Google Scholar
• Lindner, M., Bäumler, M., and Stäbler, A., 2018. Inter-correlation among the hydrophilic–lipophilic balance, surfactant system, viscosity, particle size, and stability of candelilla wax-based dispersions. Coatings, 8 (12), 4691–4618.
   Web of Science ®Google Scholar
• Marwah, H., et al., 2016. Permeation enhancer strategies in transdermal drug delivery. Drug delivery, 23, 564–578.
   PubMed Web of Science ®Google Scholar
• Pereira, M.N., et al., 2017. Solid effervescent formulations as new approach for topical minoxidil delivery. European journal of pharmaceutical sciences, 96, 411–419.
   PubMed Web of Science ®Google Scholar
• Rizwan, M., et al., 2010. Enhanced transdermal delivery of carvedilol using nanoemulsion as a vehicle. Journal of experimental nanoscience, 5 (5), 390–411.
   Web of Science ®Google Scholar
• Rocha, KaD., et al., 2017. Voriconazole-loaded nanostructured lipid carriers (NLC) for drug delivery in deeper regions of the nail plate. International journal of pharmaceutics, 531 (1), 292–298.
   PubMed Web of Science ®Google Scholar
• Sanjula, B., et al., 2009. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. Journal of drug targeting, 17 (3), 249–256.
   PubMed Web of Science ®Google Scholar
• Santos, A.C., et al., 2020. Topical minoxidil-loaded nanotechnology strategies. Cosmetics, 7 (2), 21.
   Google Scholar
• Sapra, B., Jain, S., and Tiwary, A.K., 2009a. Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study. AAPS pharmscitech, 10 (1), 199–210.
   PubMed Web of Science ®Google Scholar
• Sapra, B., Jain, S., and Tiwary, A.K., 2009b. Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture. Drug development and industrial pharmacy, 35, 1230–1241.
   PubMed Web of Science ®Google Scholar
• Severino, P., et al., 2011. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids and surfaces B: biointerfaces, 86 (1), 125–130.
   PubMed Web of Science ®Google Scholar
• Silva, L.A.D., et al., 2017. Selection of excipients for the development of carvedilol loaded lipid-based drug delivery systems. Journal of thermal analysis and calorimetry, 130 (3), 1593–1604.
   Web of Science ®Google Scholar
• Silva, L.A.D., 2017. Desenvolvimento de sistemas automicroemulsionáveis sólidos de liberação entérica do carvedilol pela técnica hot-melt extrusion: da seleção dos adjuvantes à obtenção e caracterização in vitro da formulação otimizada. Dissertation (PhD). Universidade Federal de Goias.
   Google Scholar
• Silva, L.A.D., et al., 2016. Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based drug delivery systems. Journal of thermal analysis and calorimetry, 123 (3), 2337–2344.
   Web of Science ®Google Scholar
• Souza, L.G., et al., 2011. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. European journal of pharmaceutics and biopharmaceutics, 79, 189–196.
   PubMed Web of Science ®Google Scholar
• Taveira, S.F., et al., 2018. Cyclodextrin-based poly(pseudo)rotaxanes for transdermal delivery of carvedilol. Carbohydrate polymers, 200, 278–288.
   PubMed Web of Science ®Google Scholar
• Teixeira, F.V., et al., 2018. Preformulation studies to guide the development of raloxifene lipid-based delivery systems. Journal of thermal analysis and calorimetry, 132 (1), 365–371.
   Web of Science ®Google Scholar
• Tosta, F.V., et al., 2014. Paclitaxel-loaded lipid nanoparticles for topical application: the influence of oil content on lipid dynamic behavior, stability, and drug skin penetration. Journal of nanoparticle research, 16, 2782.
   Web of Science ®Google Scholar
• Venâncio, J.H., et al., 2017. Topotecan-loaded lipid nanoparticles as a viable tool for the topical treatment of skin cancers. Journal of pharmacy and pharmacology, 69 (10), 1318–1326.
   PubMed Web of Science ®Google Scholar
• Wissing, S.A., Kayser, O., and Müller, R.H., 2004. Solid lipid nanoparticles for parenteral drug delivery. Advanced drug delivery reviews, 56, 1257–1272.
   PubMed Web of Science ®Google Scholar